March 20, 2019
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Ocular Therapeutix posts net loss for 2018
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Ocular Therapeutix reported a fourth quarter 2018 net loss of $17.4 million, or $0.42 per share, compared with 2017’s fourth quarter loss of $13.1 million, or $0.44 per share.
For the full year, net loss totaled $60 million compared with a net loss of $63 million in 2017, according to a press release.
Total costs and operating expenses were $17.8 million for the quarter compared with $13.2 million a year ago, while expenses for 2018 were $61.1 million compared with $63.8 million in 2017.
Total revenue for 2018 was nearly $2 million, up slightly from $1.9 the previous year.
The company had $54.1 million in cash and cash equivalents as of Dec. 31, 2018.